LONDON (Alliance News) - Clinigen Group PLC said Monday that it has begun a named patient programme to provide Abiogen Pharma SpA's Nerixia to patients with Osteogenesis imperfecta. Clinigen will supply the drug to countries in the EU, with the exception of Italy where it is already commerc Read More

Clinigen Agrees New 4-Year GBP35 Million Debt Facility With RBS

4th Apr 2014 08:48

LONDON (Alliance News) - Clinigen Group PLC Friday said it has secured a new four year GBP35 million multi-currency revolving credit facility, with the option for a GBP15 million top-up. The specialty pharmaceuticals company said the new facility is secured on its tangible and intangible as Read More

UK MORNING BRIEFING: Matomy Media Pulls IPO; CFOs Come And Go

4th Apr 2014 07:22

LONDON (Alliance News) - UK shares have opened slightly higher Friday, as the market awaits US jobs figures later in the day. Matomy Media Group Ltd became the first initial public offering to be pulled in London in 2014. The CFO role was front and centre Read More

UK BROKER RATINGS: SocGen Cuts Price Targets For Supermarkets

31st Mar 2014 09:09

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning: ---------- FTSE 100 ---------- SOCGEN CUTS TESCO PRICE TARGET TO 240 (270) PENCE - 'SELL' ---------- SOCGEN CUTS MORRISON PRICE TARGET TO 170 (200) Read More

Clinigen Acquires Oncology Support Therapy Savene From SpePharm

31st Mar 2014 08:57

LONDON (Alliance News) - Clinigen Group PLC said Monday that it had acquired oncology support therapy treatment Savene from SpePharm AG, a majority owned affiliate of Netherlands based Norgine B.V. Savene is used to treat the leakage, or accidental injection, of anti-cancer drugs into tissu Read More

The European Commission Lifts Clinigen Marketing Suspension For Vibativ

18th Mar 2014 10:47

LONDON (Alliance News) - Clinigen Group PLC said Tuesday that the European Commission has lifted the Europe-wide marketing suspension on its anti-bacterial treatment, Vibativ. Clinigen said that the EC's decision follows positive opinion from the European Medicines Agency's Committee for Me Read More

FTSE 100 Latest

Value8,809.74

Change53.53